Shred 10ml – 10 vials

Shred is a compounded injectable research formulation crafted as a streamlined, high-efficacy lipotropic “shredding” blend, combining moderate-to-high dose L-Carnitine with the core MIC (Methionine/Inositol/Choline) components and supportive B-vitamins in a sterile aqueous solution for intramuscular or subcutaneous administration. Typical per mL composition includes L-Carnitine 200 mg, Vitamin B12 (methylcobalamin or cyanocobalamin) 250 mcg, Pyridoxine HCl (Vitamin B6) 25 mg, Inositol 50 mg, Methionine 25 mg, and Choline (as bitartrate or chloride) 50 mg.
It functions through synergistic pathways focused on fat mobilization, mitochondrial oxidation, hepatic lipid handling, and metabolic energy support: L-Carnitine serves as the primary shuttle for long-chain fatty acids into mitochondria, facilitating β-oxidation and ATP production to promote fat utilization as fuel during caloric deficit or exercise; the MIC triad supports efficient liver fat processing (Methionine as a methyl donor for homocysteine metabolism and SAMe-dependent fat export, Inositol for insulin sensitivity and lipid regulation, Choline for phosphatidylcholine synthesis and VLDL assembly to prevent hepatic steatosis); Vitamin B12 enhances methylation cycles, energy metabolism, and red blood cell formation for sustained vitality; while Vitamin B6 aids amino acid transamination, homocysteine reduction, and neurotransmitter support, contributing to metabolic flexibility and stress resilience during fat-loss protocols.
In preclinical, wellness, and performance research models (commonly investigated as an adjunct to training regimens, caloric restriction, or body recomposition strategies), this balanced blend is explored for accelerating lipolysis, enhancing fat oxidation (particularly in stubborn adipose depots), reducing liver lipid accumulation, improving mitochondrial efficiency and endurance, optimizing energy availability without heavy stimulant reliance, and supporting lean mass preservation through improved nutrient partitioning and recovery. The injectable delivery ensures rapid systemic bioavailability of these water-soluble compounds, potentially surpassing oral equivalents in metabolic impact.
Shred is utilized in research to investigate mechanisms of carnitine-mediated fatty acid transport combined with lipotropic synergy, roles of B6 and B12 in methylation and energy pathway optimization during lipolytic stress, hepatic lipid homeostasis and fat export efficiency, supportive strategies for aggressive fat-loss or “shredding” protocols, body composition enhancement in athletic or metabolic models, adaptive thermogenesis, mitochondrial bioenergetics under energy demand, and the broader contributions of this targeted nutrient profile to fat-to-energy conversion, metabolic reprogramming, cellular resilience, and long-term optimization of physique and performance outcomes